List of Tables
Table 1. Global Brucellosis Vaccines Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Brucellosis Vaccines Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global Brucellosis Vaccines Market Competitive Situation by Manufacturers in 2025
Table 4. Global Brucellosis Vaccines Sales (M Doses) of Key Manufacturers (2021–2026)
Table 5. Global Brucellosis Vaccines Sales Market Share by Manufacturers (2021–2026)
Table 6. Global Brucellosis Vaccines Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global Brucellosis Vaccines Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market Brucellosis Vaccines Average Price (USD/K Doses) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of Brucellosis Vaccines, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of Brucellosis Vaccines, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of Brucellosis Vaccines, Product Types and Applications
Table 12. Global Key Manufacturers of Brucellosis Vaccines, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Brucellosis Vaccines Companies by Tier (Tier 1, Tier 2, Tier 3), based on Brucellosis Vaccines Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Brucellosis Vaccines Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global Brucellosis Vaccines Sales by Region (M Doses), 2021–2026
Table 18. Global Brucellosis Vaccines Sales Market Share by Region (2021–2026)
Table 19. Global Brucellosis Vaccines Sales by Region (M Doses), 2027–2032
Table 20. Global Brucellosis Vaccines Sales Market Share by Region (2027–2032)
Table 21. Global Brucellosis Vaccines Revenue by Region (US$ Million), 2021–2026
Table 22. Global Brucellosis Vaccines Revenue Market Share by Region (2021–2026)
Table 23. Global Brucellosis Vaccines Revenue by Region (US$ Million), 2027–2032
Table 24. Global Brucellosis Vaccines Revenue Market Share by Region (2027–2032)
Table 25. North America Brucellosis Vaccines Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America Brucellosis Vaccines Sales by Country (M Doses), 2021–2026
Table 27. North America Brucellosis Vaccines Sales by Country (M Doses), 2027–2032
Table 28. North America Brucellosis Vaccines Revenue by Country (US$ Million), 2021–2026
Table 29. North America Brucellosis Vaccines Revenue by Country (US$ Million), 2027–2032
Table 30. Europe Brucellosis Vaccines Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe Brucellosis Vaccines Sales by Country (M Doses), 2021–2026
Table 32. Europe Brucellosis Vaccines Sales by Country (M Doses), 2027–2032
Table 33. Europe Brucellosis Vaccines Revenue by Country (US$ Million), 2021–2026
Table 34. Europe Brucellosis Vaccines Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific Brucellosis Vaccines Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific Brucellosis Vaccines Sales by Region (M Doses), 2021–2026
Table 37. Asia Pacific Brucellosis Vaccines Sales by Region (M Doses), 2027–2032
Table 38. Asia Pacific Brucellosis Vaccines Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific Brucellosis Vaccines Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America Brucellosis Vaccines Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America Brucellosis Vaccines Sales by Country (M Doses), 2021–2026
Table 42. Latin America Brucellosis Vaccines Sales by Country (M Doses), 2027–2032
Table 43. Latin America Brucellosis Vaccines Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America Brucellosis Vaccines Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa Brucellosis Vaccines Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa Brucellosis Vaccines Sales by Country (M Doses), 2021–2026
Table 47. Middle East and Africa Brucellosis Vaccines Sales by Country (M Doses), 2027–2032
Table 48. Middle East and Africa Brucellosis Vaccines Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa Brucellosis Vaccines Revenue by Country (US$ Million), 2027–2032
Table 50. Global Brucellosis Vaccines Sales (M Doses) by Type (2021–2026)
Table 51. Global Brucellosis Vaccines Sales (M Doses) by Type (2027–2032)
Table 52. Global Brucellosis Vaccines Sales Market Share by Type (2021–2026)
Table 53. Global Brucellosis Vaccines Sales Market Share by Type (2027–2032)
Table 54. Global Brucellosis Vaccines Revenue (US$ Million) by Type (2021–2026)
Table 55. Global Brucellosis Vaccines Revenue (US$ Million) by Type (2027–2032)
Table 56. Global Brucellosis Vaccines Revenue Market Share by Type (2021–2026)
Table 57. Global Brucellosis Vaccines Revenue Market Share by Type (2027–2032)
Table 58. Global Brucellosis Vaccines Price (USD/K Doses) by Type (2021–2026)
Table 59. Global Brucellosis Vaccines Price (USD/K Doses) by Type (2027–2032)
Table 60. Global Brucellosis Vaccines Sales (M Doses) by Application (2021–2026)
Table 61. Global Brucellosis Vaccines Sales (M Doses) by Application (2027–2032)
Table 62. Global Brucellosis Vaccines Sales Market Share by Application (2021–2026)
Table 63. Global Brucellosis Vaccines Sales Market Share by Application (2027–2032)
Table 64. Global Brucellosis Vaccines Revenue (US$ Million) by Application (2021–2026)
Table 65. Global Brucellosis Vaccines Revenue (US$ Million) by Application (2027–2032)
Table 66. Global Brucellosis Vaccines Revenue Market Share by Application (2021–2026)
Table 67. Global Brucellosis Vaccines Revenue Market Share by Application (2027–2032)
Table 68. Global Brucellosis Vaccines Price (USD/K Doses) by Application (2021–2026)
Table 69. Global Brucellosis Vaccines Price (USD/K Doses) by Application (2027–2032)
Table 70. Jinyu Company Information
Table 71. Jinyu Description and Business Overview
Table 72. Jinyu Brucellosis Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses), and Gross Margin (2021–2026)
Table 73. Jinyu Brucellosis Vaccines Product
Table 74. Jinyu Recent Developments/Updates
Table 75. Colorado Serum Company Information
Table 76. Colorado Serum Description and Business Overview
Table 77. Colorado Serum Brucellosis Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses), and Gross Margin (2021–2026)
Table 78. Colorado Serum Brucellosis Vaccines Product
Table 79. Colorado Serum Recent Developments/Updates
Table 80. Boehringer Ingelheim Company Information
Table 81. Boehringer Ingelheim Description and Business Overview
Table 82. Boehringer Ingelheim Brucellosis Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses), and Gross Margin (2021–2026)
Table 83. Boehringer Ingelheim Brucellosis Vaccines Product
Table 84. Boehringer Ingelheim Recent Developments/Updates
Table 85. Biogenesis-Bago Company Information
Table 86. Biogenesis-Bago Description and Business Overview
Table 87. Biogenesis-Bago Brucellosis Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses), and Gross Margin (2021–2026)
Table 88. Biogenesis-Bago Brucellosis Vaccines Product
Table 89. Biogenesis-Bago Recent Developments/Updates
Table 90. Vetal Company Company Information
Table 91. Vetal Company Description and Business Overview
Table 92. Vetal Company Brucellosis Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses), and Gross Margin (2021–2026)
Table 93. Vetal Company Brucellosis Vaccines Product
Table 94. Vetal Company Recent Developments/Updates
Table 95. CZ Veterinaria Company Information
Table 96. CZ Veterinaria Description and Business Overview
Table 97. CZ Veterinaria Brucellosis Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses), and Gross Margin (2021–2026)
Table 98. CZ Veterinaria Brucellosis Vaccines Product
Table 99. CZ Veterinaria Recent Developments/Updates
Table 100. SYVA Laboratorios Company Information
Table 101. SYVA Laboratorios Description and Business Overview
Table 102. SYVA Laboratorios Brucellosis Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses), and Gross Margin (2021–2026)
Table 103. SYVA Laboratorios Brucellosis Vaccines Product
Table 104. SYVA Laboratorios Recent Developments/Updates
Table 105. Indian Immunologicals Company Information
Table 106. Indian Immunologicals Description and Business Overview
Table 107. Indian Immunologicals Brucellosis Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses), and Gross Margin (2021–2026)
Table 108. Indian Immunologicals Brucellosis Vaccines Product
Table 109. Indian Immunologicals Recent Developments/Updates
Table 110. Qilu Company Information
Table 111. Qilu Description and Business Overview
Table 112. Qilu Brucellosis Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses), and Gross Margin (2021–2026)
Table 113. Qilu Brucellosis Vaccines Product
Table 114. Qilu Recent Developments/Updates
Table 115. Tecnovax Company Information
Table 116. Tecnovax Description and Business Overview
Table 117. Tecnovax Brucellosis Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses), and Gross Margin (2021–2026)
Table 118. Tecnovax Brucellosis Vaccines Product
Table 119. Tecnovax Recent Developments/Updates
Table 120. Hester Biosciences Company Information
Table 121. Hester Biosciences Description and Business Overview
Table 122. Hester Biosciences Brucellosis Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses), and Gross Margin (2021–2026)
Table 123. Hester Biosciences Brucellosis Vaccines Product
Table 124. Hester Biosciences Recent Developments/Updates
Table 125. Zoetis Company Information
Table 126. Zoetis Description and Business Overview
Table 127. Zoetis Brucellosis Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses), and Gross Margin (2021–2026)
Table 128. Zoetis Brucellosis Vaccines Product
Table 129. Zoetis Recent Developments/Updates
Table 130. Onderstepoort Biological Company Information
Table 131. Onderstepoort Biological Description and Business Overview
Table 132. Onderstepoort Biological Brucellosis Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses), and Gross Margin (2021–2026)
Table 133. Onderstepoort Biological Brucellosis Vaccines Product
Table 134. Onderstepoort Biological Recent Developments/Updates
Table 135. Instituto Rosenbusch Company Information
Table 136. Instituto Rosenbusch Description and Business Overview
Table 137. Instituto Rosenbusch Brucellosis Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses), and Gross Margin (2021–2026)
Table 138. Instituto Rosenbusch Brucellosis Vaccines Product
Table 139. Instituto Rosenbusch Recent Developments/Updates
Table 140. Ceva Sante Animale Company Information
Table 141. Ceva Sante Animale Description and Business Overview
Table 142. Ceva Sante Animale Brucellosis Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses), and Gross Margin (2021–2026)
Table 143. Ceva Sante Animale Brucellosis Vaccines Product
Table 144. Ceva Sante Animale Recent Developments/Updates
Table 145. Calier & Biologicos Laverlam Company Information
Table 146. Calier & Biologicos Laverlam Description and Business Overview
Table 147. Calier & Biologicos Laverlam Brucellosis Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses), and Gross Margin (2021–2026)
Table 148. Calier & Biologicos Laverlam Brucellosis Vaccines Product
Table 149. Calier & Biologicos Laverlam Recent Developments/Updates
Table 150. Biovet Company Information
Table 151. Biovet Description and Business Overview
Table 152. Biovet Brucellosis Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses), and Gross Margin (2021–2026)
Table 153. Biovet Brucellosis Vaccines Product
Table 154. Biovet Recent Developments/Updates
Table 155. Key Raw Materials Lists
Table 156. Raw Materials Key Suppliers Lists
Table 157. Brucellosis Vaccines Distributors List
Table 158. Brucellosis Vaccines Customers List
Table 159. Brucellosis Vaccines Market Trends
Table 160. Brucellosis Vaccines Market Drivers
Table 161. Brucellosis Vaccines Market Challenges
Table 162. Brucellosis Vaccines Market Restraints
Table 163. Research Programs/Design for This Report
Table 164. Key Data Information from Secondary Sources
Table 165. Key Data Information from Primary Sources
Table 166. Authors List of This Report
List of Figures
Figure 1. Product Picture of Brucellosis Vaccines
Figure 2. Global Brucellosis Vaccines Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Brucellosis Vaccines Market Share by Type: 2025 & 2032
Figure 4. S19 Vaccine Product Picture
Figure 5. RB51 Vaccine Strain Product Picture
Figure 6. Global Brucellosis Vaccines Market Value by Application (US$ Million), 2021–2032
Figure 7. Global Brucellosis Vaccines Market Share by Application: 2025 & 2032
Figure 8. Cattle
Figure 9. Sheep
Figure 10. Others
Figure 11. Global Brucellosis Vaccines Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 12. Global Brucellosis Vaccines Market Size (US$ Million), 2021–2032
Figure 13. Global Brucellosis Vaccines Sales (M Doses), 2021–2032
Figure 14. Global Brucellosis Vaccines Average Price (USD/K Doses), 2021–2032
Figure 15. Brucellosis Vaccines Report Years Considered
Figure 16. Brucellosis Vaccines Sales Share by Manufacturers in 2025
Figure 17. Global Brucellosis Vaccines Revenue Share by Manufacturers in 2025
Figure 18. Top 5 and Top 10 Global Brucellosis Vaccines Players: Market Share by Revenue in Brucellosis Vaccines in 2025
Figure 19. Brucellosis Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 20. Global Brucellosis Vaccines Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 21. North America Brucellosis Vaccines Sales Market Share by Country (2021–2032)
Figure 22. North America Brucellosis Vaccines Revenue Market Share by Country (2021–2032)
Figure 23. U.S. Brucellosis Vaccines Revenue Growth Rate (US$ Million), 2021–2032
Figure 24. Canada Brucellosis Vaccines Revenue Growth Rate (US$ Million), 2021–2032
Figure 25. Europe Brucellosis Vaccines Sales Market Share by Country (2021–2032)
Figure 26. Europe Brucellosis Vaccines Revenue Market Share by Country (2021–2032)
Figure 27. Germany Brucellosis Vaccines Revenue Growth Rate (US$ Million), 2021–2032
Figure 28. France Brucellosis Vaccines Revenue Growth Rate (US$ Million), 2021–2032
Figure 29. U.K. Brucellosis Vaccines Revenue Growth Rate (US$ Million), 2021–2032
Figure 30. Italy Brucellosis Vaccines Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. Russia Brucellosis Vaccines Revenue Growth Rate (US$ Million), 2021–2032
Figure 32. Asia Pacific Brucellosis Vaccines Sales Market Share by Region (2021–2032)
Figure 33. Asia Pacific Brucellosis Vaccines Revenue Market Share by Region (2021–2032)
Figure 34. China Brucellosis Vaccines Revenue Growth Rate (US$ Million), 2021–2032
Figure 35. Japan Brucellosis Vaccines Revenue Growth Rate (US$ Million), 2021–2032
Figure 36. South Korea Brucellosis Vaccines Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. India Brucellosis Vaccines Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. Australia Brucellosis Vaccines Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. China Taiwan Brucellosis Vaccines Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. Indonesia Brucellosis Vaccines Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. Thailand Brucellosis Vaccines Revenue Growth Rate (US$ Million), 2021–2032
Figure 42. Malaysia Brucellosis Vaccines Revenue Growth Rate (US$ Million), 2021–2032
Figure 43. Latin America Brucellosis Vaccines Sales Market Share by Country (2021–2032)
Figure 44. Latin America Brucellosis Vaccines Revenue Market Share by Country (2021–2032)
Figure 45. Mexico Brucellosis Vaccines Revenue Growth Rate (US$ Million), 2021–2032
Figure 46. Brazil Brucellosis Vaccines Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. Argentina Brucellosis Vaccines Revenue Growth Rate (US$ Million), 2021–2032
Figure 48. Middle East and Africa Brucellosis Vaccines Sales Market Share by Country (2021–2032)
Figure 49. Middle East and Africa Brucellosis Vaccines Revenue Market Share by Country (2021–2032)
Figure 50. Turkey Brucellosis Vaccines Revenue Growth Rate (US$ Million), 2021–2032
Figure 51. Saudi Arabia Brucellosis Vaccines Revenue Growth Rate (US$ Million), 2021–2032
Figure 52. UAE Brucellosis Vaccines Revenue Growth Rate (US$ Million), 2021–2032
Figure 53. Global Sales Market Share of Brucellosis Vaccines by Type (2021–2032)
Figure 54. Global Revenue Market Share of Brucellosis Vaccines by Type (2021–2032)
Figure 55. Global Brucellosis Vaccines Price (USD/K Doses) by Type (2021–2032)
Figure 56. Global Sales Market Share of Brucellosis Vaccines by Application (2021–2032)
Figure 57. Global Revenue Market Share of Brucellosis Vaccines by Application (2021–2032)
Figure 58. Global Brucellosis Vaccines Price (USD/K Doses) by Application (2021–2032)
Figure 59. Brucellosis Vaccines Value Chain
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
